Our study revealed that CAV3 plays a significant role in the development of DCM. Mechanistically, we demonstrated that CAV3 overexpression can inhibit the degradation of NDUFA10 via the lysosomal pathway. This evidence concerns the gene NDUFA10 and familial dilated cardiomyopathy.